Piramal Enterprises Ltd

Piramal Enterprises Ltd | Sector: Finance | ISIN: INE140A01024

₹ 642.60 (-1.09%) icon

27 Mar, 2023, 9:23:09 AM
Open
₹ 650.30
Prev. Close
₹ 649.65
Turnover(lac)
₹ 748.02
Day's High
₹ 651.90
Day's Low
₹ 641.00
52 Wk High
₹ 1,303.68
52 Wk Low
₹ 645.00
Book Value
₹ 1,571.74
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 15,336.53
P/E
4.90
EPS
132.64
Div. Yield
5.07

Stock View

info icon
Edit Image

STRONG BUY

Target | 13 Feb, 2023

1,102.78 (69.75%)

Piramal Enterprises Limited (PEL) is an India-based company that is engaged in diversified business, such as financial services and pharmaceuticals. PEL’s financial services offer a range of... Read More

KEY RATIOS

sector: Finance

  • CMP

    as on 3/27/2023 9:23:09 AM

    ₹ 642.6 -7.05 -1.09
  • Open
  • ₹ 650.3
  • Prev. Close
  • ₹ 649.65
  • Turnover(Lac.)
  • ₹ 748
  • Day's High
  • ₹ 651.9
  • Day's Low
  • ₹ 641
  • 52 Week's High
  • ₹ 1,303.68
  • 52 Week's Low
  • ₹ 645
  • Book Value
  • ₹ 1,571.74
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 15,336.53
  • P/E
  • 4.9
  • EPS
  • 132.64
  • Divi. Yield
  • 5.07

Corporate Actions

01 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2023

12:00 AM

28 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Nov , 2022

12:00 AM

03 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

26 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

26 May , 2022

12:00 AM

AGM

Announcement date: 26 May , 2022

View Details

22 Jul , 2022

12:00 AM

26 May , 2022

12:00 AM

Dividend

Dividend amount: 33
Announcement date: 26 May , 2022

View Details

14 May , 2022

12:00 AM

19 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Apr , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

SHAREHOLDING SNAPSHOT
27 March , 2023 | 09:23 AM

PROMOTER - TOTAL43.48%

Indian: 43.48%

Foreign: 0%

NON-PROMOTER - TOTAL 56.02%

Institutions: 39.32%

Non-Institutions: 16.71%

CUSTODIES - 0.49%

Custodies: 0.49%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Piramal Enterprises Ltd News and Update

Image not found
  • 24 March, 2023 |
  • 4:04 PM

The initial batch of EV charging points has been set up by Jio-bp at Piramal Vaikunth located in Thane.

Image not found
  • IIFL News Service |
  • 24 March, 2023 |
  • 4:03 PM
Article Image
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Piramal Enterprises Ltd

  • Ajay G Piramal

  • Chairman
  • Swati A Piramal

  • Vice Chairperson
  • Nandini Piramal

  • Executive Director
  • S Rama Dorai

  • Independent Director
  • Anand Piramal

  • Non Executive Director
  • Bipin Singh

  • Company Secretary
  • Vijay Shah

  • Non Executive Director
  • Suhail Nathani

  • Independent Director
  • KUNAL BAHL

  • Independent Director
  • Anjali Bansal

  • Independent Director
  • Shikha Sharma

  • Non Executive Director
  • Puneet Yadu Dalmia

  • Independent Director
  • Anita M George

  • Independent Director
  • Rajiv Mehrishi.

  • Independent Director

Summary

Piramal Enterprises Limited (PEL), erstwhile Piramal Healthcare Limited, is the flagship company of the Piramal Group, led by Ajay Piramal. The Company is one of Indias large diversified companies, with a presence in Financial Services, Pharmaceuticals and Healthcare Insights & Analytics. In Pharma, through an end-to-end manufacturing capabilities across 13 global facilities and a large global distribution network to over 100 countries, PEL sells a portfolio of niche differentiated Pharma products and provides an entire pool of Pharma services (including in the areas of injectable, HPAPI etc.). PELs Global Pharma business has a strong product portfolio of niche differentiated branded generic products that are difficult to manufacture, sell or distribute. PELs Contract Development and Manufacturing Organisation (CDMO) services segment offers end-to-end solutions across the drug life cycle through a globally integrated network of facilities. PELs India consumer products division caters to the Indian self-care market. PELs OTC range comprises of 18 major brands from the pharmaceutical and personal care space, in diverse product categories like Vitamins & Nutrition, Dermatological & Antacids, Analgesics and Baby Care.PELs Healthcare Insights & Analytics business is the premier provider of healthcare analytics, data & insight products and services to the worlds leading pharma, biotech and medical technology companies and enables them to take informed business decisions.In... Read More


Reports by Piramal Enterprises Ltd


Reports by Piramal Enterprises Ltd